We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 975

Health Apps: Convenience vs. Security Risks
  • Jackson Lewis PC
  • USA
  • May 9 2018

The pace of innovation in healthcare today has produced an amazing increase in the number of available mobile apps for health-related information


FDA Issues Two Guidances on Next Generation Sequencing
  • Reed Smith LLP
  • USA
  • April 24 2018

This guest post is from Reed Smith‘s Matt Jacobson, who is keeping us up to date with the FDA’s initiatives concerning pharmacogenomics and


Minnesota Court Excludes Plaintiff Expert Opinions For Lack of General Acceptance
  • Reed Smith LLP
  • USA
  • March 21 2018

All of us - defense lawyers, plaintiff lawyers, and judges - tend to assume that the federal Daubert standard for admissibility of expert testimony is


Life Sciences: Compliance and enforcement in the USA
  • Perkins Coie LLP
  • USA
  • October 11 2017

A structured guide to compliance and dishonest practices in the USA


The Past, Present, and Future of Government Regulation of Off-Label Communications - Part 4
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • August 14 2017

Picking up from my last installment of this series exploring the regulatory history of off-label communication, this post highlights some recent


Fifth Circuit Affirms Defense Verdict and Dismissals of Off-Label FCA Claims
  • Sidley Austin LLP
  • USA
  • June 13 2017

Last week, the Fifth Circuit affirmed a defense verdict and the earlier dismissal of several False Claims Act claims related to the alleged off-label


Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • June 12 2017

Senate Republicans continue intra-party discussions on changes to House-passed legislation replacing the Affordable Care Act (ACA


President Trump’s Proposed FY 2018 Budget Spares Medicare, But Calls for Deep Medicaid Cuts & FDA User Fee Hikes
  • Reed Smith LLP
  • USA
  • June 1 2017

President Trump has released his FY 2018 budget proposal, which the Administration dubs "A New Foundation for American Greatness." The proposed


New FDA Commissioner Hits the Ground Running
  • Foley & Lardner LLP
  • USA
  • May 30 2017

Fresh off his noticeably smooth confirmation, the new Commissioner of Food and Drugs, Dr. Scott Gottlieb, appeared before Congress last Thursday and


Let Food Be Thy Medicine, But Mind Your Words
  • Davis Wright Tremaine LLP
  • USA
  • May 24 2017

A tweet last week from Project Nosh set my food-labeling-lawyer-head buzzing: “Consumers are looking for snacks that aren’t just empty calories